Last updated: Oct 17, 2026, 5:30 AM UTC
Latest Insider Sales $100K+
Browse the latest insider trading activity on the sell side with a total transaction size of $100,000 or more, reported in SEC Form 4 filings. The most recent is an Adaptive Biotechnologies Corp (ADPT) president and coo's sale of 23,762 shares, valued at about $593,083. Alongside the dollar amount, you can see how much each sale changed the insider's holdings. Use the color tags and SEC filing links to check for employee stock plans, dividend reinvestment, and prearranged trades among the insider trading activity.
These filings are deferred by 6 hours & limited to 50 category trades. Sign up for real time updates and 20 years of data.
View Latest Alerts
Notable Patterns
Latest Cluster Buys
Latest Penny Stock Buys
Biggest Buys This Week
Biggest Buys This Month
Latest Insider Trading - All Filings
Latest Insider Purchases
Latest Insider Purchases $25K+
Latest Insider Purchases $100K+
Latest Officer Purchases $25K+
Latest Officer Purchases $100K+
Latest CEO/CFO Purchases $25K+
Latest CEO/CFO Purchases $100K+
Latest Insider Sales
Latest Insider Sales $25K+
Latest Insider Sales $100K+
Latest Officer Sales $25K+
Latest Officer Sales $100K+
Latest CEO/CFO Sales $25K+
Latest CEO/CFO Sales $100K+
Loading alerts
50 trades of 30503 total
| File Date | Date of Earliest Transaction | Date of Latest Transaction | Ticker Symbol | Company | Insider Name | Insider Title | Buy/Sell | Transaction Count | Shares Transacted | Price | Total Transaction Value | Total Shares Owned After Transaction | Position Size Change | SEC Link |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-16 | ADPT | Adaptive Biotechnologies Corp | Rubinstein Julie | President and COO | Sell | 4 | 23,762 | $24.96 | $593,083.18 | 377,802 | 5.92% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | ADPT | Adaptive Biotechnologies Corp | Rubinstein Julie | President and COO | Sell | 1 | 11,881 | $25.61 | $304,272.41 | 377,802 | 3.05% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | KTOS | Kratos Defense & Security Solutions, Inc. | Carrai Phillip D | President, STC Division | Sell | 3 | 6,500 | $39.86 | $259,116.87 | 169,196 | 3.70% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-15 | BLLN | Billiontoone, Inc. | Atay Oguzhan | Chairman and CEO | Sell | 8 | 11,000 | $99.14 | $1,090,574.72 | 149,168 | 6.87% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | ANIP | Ani Pharmaceuticals Inc | Lalwani Nikhil | PRESIDENT & CEO | Sell | 1 | 5,400 | $71.89 | $388,206.00 | 333,689 | 1.59% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | AIRJ | Airjoule Technologies Corp. | Jore Matthew B | Chief Executive Officer | Sell | 1 | 50,000 | $3.06 | $153,165.00 | 7,698,020 | 0.65% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-14 | RAL | Ralliant Corp | Newcombe Tamara S. | President and CEO | Sell | 1 | 12,936 | $70.58 | $913,022.88 | 246,897 | 4.98% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-14 | RDDT | Reddit, Inc. | Wong Jennifer L. | Chief Operating Officer | Sell | 8 | 60,000 | $150.55 | $9,032,837.17 | 1,012,226 | 5.60% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | CORT | Corcept Therapeutics Inc | Wilson James N | Director | Sell | 3 | 10,000 | $114.81 | $1,148,082.74 | 1,054,543 | 0.94% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | URBN | Urban Outfitters Inc | Cherken Harry S Jr | Director | Sell | 1 | 5,000 | $87.06 | $435,310.00 | 494,315 | 1.00% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-16 | 2026-10-16 | WSM | Williams Sonoma Inc | Finucane Anne A. | Director | Sell | 2 | 794 | $252.14 | $200,197.14 | 9,404 | 7.79% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | MDT | Medtronic Plc | Marinaro Michael | EVP, Pres MedSurg and Americas | Sell | 1 | 10,420 | $96.00 | $1,000,320.00 | 105,916 | 8.96% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | MDT | Medtronic Plc | Martha Geoffrey | Chairman and CEO | Sell | 1 | 50,000 | $95.00 | $4,750,000.00 | 277,866 | 15.25% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-14 | PACS | Pacs Group, Inc. | Jergensen Joshua | President & COO | Sell | 1 | 40,000 | $44.50 | $1,780,004.00 | 2,456,320 | 1.60% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-16 | PACS | Pacs Group, Inc. | Murray Jason Hulse | Co-Founder, CEO & Chairman | Sell | 6 | 118,729 | $47.29 | $5,614,667.37 | 54,316,520 | 0.22% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | PL | Planet Labs Pbc | Robinson Kristen | Director | Sell | 1 | 40,000 | $14.14 | $565,560.00 | 182,897 | 17.95% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-14 | CRSP | Crispr Therapeutics Ag | George Simeon | Director | Sell | 1 | 14,514 | $49.63 | $720,373.36 | 15,486 | 48.38% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-16 | LIFE | Ethos Technologies Inc. | Colis Peter George | CEO and Secretary | Sell | 7 | 120,000 | $38.39 | $4,607,379.28 | 1,537,360 | 7.24% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | SNPS | Synopsys Inc | Ghazi Sassine | PRESIDENT AND CEO | Sell | 1 | 14,604 | $462.84 | $6,759,359.17 | 76,865 | 15.97% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-14 | PTCT | Ptc Therapeutics, Inc. | Schmertzler Michael | Director | Sell | 2 | 2,500 | $59.61 | $149,036.84 | 1,291,594 | 0.19% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | CDNS | Cadence Design Systems Inc | Cunningham Paul | Sr. Vice President | Sell | 1 | 2,000 | $324.13 | $648,260.00 | 119,612 | 1.64% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-16 | 2026-10-15 | 2026-10-15 | MPLT | Maplight Therapeutics, Inc. | Kroeger Christopher A. | Chief Executive Officer | Sell | 1 | 73,691 | $8.08 | $595,423.28 | 1,195,909 | 5.80% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-16 | 2026-10-15 | 2026-10-15 | MPLT | Maplight Therapeutics, Inc. | Foff Erin Pennock | Chief Medical Officer | Sell | 1 | 15,355 | $8.08 | $124,068.40 | 296,906 | 4.92% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | AMBQ | Ambiq Micro, Inc. | Hanson Scott Mclean | Chief Technology Officer | Sell | 4 | 7,000 | $51.00 | $357,008.35 | 212,546 | 3.19% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-10-16 | 2026-10-15 | 2026-10-15 | ODC | Oil-Dri Corp Of America | Lamson Christopher B | Group Vice President | Sell | 1 | 7,000 | $80.27 | $561,890.00 | 4,453 | 61.12% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | AMBQ | Ambiq Micro, Inc. | Esaka Fumihide | Chief Executive Officer | Sell | 4 | 5,000 | $51.00 | $255,017.48 | 443,900 | 1.11% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | CHWY | Chewy, Inc. | Billings William G. | Chief Accounting Officer | Sell | 1 | 17,283 | $21.00 | $362,943.00 | 39,772 | 30.29% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-14 | AMBQ | Ambiq Micro, Inc. | Chen Sean Chihhsiang | President and COO | Sell | 5 | 15,000 | $51.50 | $772,438.22 | 106,268 | 12.37% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | GRAL | Grail, Inc. | Ofman Joshua J. | Chief Executive Officer | Sell | 6 | 20,000 | $136.85 | $2,736,944.71 | 342,271 | 5.52% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-16 | 2026-10-16 | QCOM | Qualcomm Inc/De | Chaplin Ann C | EVP, GenCounsel&CorpSecretary | Sell | 1 | 1,827 | $174.75 | $319,268.25 | 25,770 | 6.62% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-16 | SIG | Signet Jewelers Ltd | Ptak Stash | * See Remarks | Sell | 2 | 2,000 | $120.00 | $240,000.00 | 20,428.21 | 8.92% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-16 | 2026-10-16 | MRVL | Marvell Technology, Inc. | Bharathi Sandeep | President, Data Center Group | Sell | 1 | 3,685 | $234.97 | $865,864.45 | 58,748 | 5.90% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | UTHR | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 12 | 9,500 | $546.65 | $5,193,199.71 | 324,443 | 2.84% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | UTHR | United Therapeutics Corp | Mahon Paul A | EVP & GENERAL COUNSEL | Sell | 6 | 8,300 | $544.30 | $4,517,708.96 | 45,172 | 15.52% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-14 | VEEV | Veeva Systems Inc | Faddis Jonathan | SVP, Gen. Counsel, Secretary | Sell | 3 | 5,198 | $299.72 | $1,557,920.41 | 4,130 | 55.72% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | MRVL | Marvell Technology, Inc. | Murphy Matthew J | Chairman of the Board and CEO | Sell | 1 | 7,500 | $235.47 | $1,766,025.00 | 768,186 | 0.97% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | TDG | Transdigm Group Inc | Reiss Joel | Co-Chief Operating Officer | Sell | 21 | 4,100 | $1,128.04 | $4,624,943.91 | 3,600 | 53.25% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | PCTY | Paylocity Holding Corp | Beauchamp Steven R | Executive Chairman | Sell | 5 | 15,000 | $165.22 | $2,478,270.00 | 1,243,389 | 1.19% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | PCTY | Paylocity Holding Corp | Sarowitz Steven I | Director, 10% Owner | Sell | 2 | 17,694 | $165.80 | $2,933,727.74 | 4,430,701 | 0.40% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | GILD | Gilead Sciences, Inc. | Dickinson Andrew D | Chief Financial Officer | Sell | 1 | 3,000 | $156.22 | $468,660.00 | 161,096 | 1.83% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | BKNG | Booking Holdings Inc. | Pisano Paulo | CHIEF HUMAN RESOURCES OFFICER | Sell | 1 | 1,500 | $163.06 | $244,590.00 | 70,400 | 2.09% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | CARG | Cargurus, Inc. | Zales Samuel | COO and President | Sell | 1 | 10,000 | $30.31 | $303,100.00 | 429,735 | 2.27% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-14 | GRND | Grindr Inc. | Katz Zachary | CLO and Head of Global Affairs | Sell | 1 | 15,227 | $15.23 | $231,907.21 | 618,000 | 2.40% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | BJ | Bj's Wholesale Club Holdings, Inc. | Felice Laura L. | EVP, Chief Financial Officer | Sell | 1 | 8,452 | $104.95 | $887,037.40 | 84,416 | 9.10% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | GILD | Gilead Sciences, Inc. | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 1 | 3,000 | $156.22 | $468,660.00 | 113,684 | 2.57% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | CTEV | Claritev Corp | Misencik Tiffani | SVP, Chief Growth Officer | Sell | 1 | 5,812 | $23.81 | $138,390.11 | 107,917 | 5.11% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-15 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | 3 | 78,369 | $217.10 | $17,013,537.68 | 1,599,258 | 4.67% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | CSW | Csw Industrials, Inc. | Armes Joseph B | Chairman, President & CEO | Sell | 1 | 1,500 | $287.04 | $430,557.60 | 64,083 | 2.29% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | PPL | Ppl Corp | Stark Wendy E | EVP & CLO | Sell | 1 | 5,406 | $35.11 | $189,804.66 | 99,220.31 | 5.17% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-10-16 | 2026-10-14 | 2026-10-14 | PAYX | Paychex Inc | Velli Joseph M | Director | Sell | 1 | 7,839 | $107.68 | $844,103.52 | 81,725 | 8.75% | View filing |
Loading alerts